Overview
- CENSIDA reports 18,895 new HIV diagnoses and 5,149 deaths in the last year, with more than 40% of cases identified at advanced stages linked to stigma and testing barriers.
- Only about 70% of people living with HIV in Mexico know their status, underscoring gaps in detection despite universal antiretroviral therapy availability.
- The Health Ministry says 2026 actions will include faster cross-institution access to antiretrovirals, expanded PrEP and PEP, a digital registry for follow-up, and protocols to safeguard continuity of care.
- Recent coverage highlights conflicting prevalence estimates that complicate planning, with WHO-cited figures near 400,000 people living with HIV versus roughly 160,000 indicated by national surveillance data.
- Transmission remains concentrated in key populations and is rising among adults aged 20–34, while 2024 approval of HIV self-testing and planned targeted Mpox vaccination are intended to bolster prevention and reduce stigma.